Aralkyl substituted piperazine compounds
AssigneeCV Therapeutics, Inc.
InventorsJeff Zablocki, Elfatih Elzein, Brent K. Blackburn, Tim Marquart, Prabha N. Ibrahim, Venkata P. Palle
Life of this patent
Estimating the term…
Loading patent…
AssigneeCV Therapeutics, Inc.
InventorsJeff Zablocki, Elfatih Elzein, Brent K. Blackburn, Tim Marquart, Prabha N. Ibrahim, Venkata P. Palle
Estimating the term…
Novel compounds of the general formula: and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subsequent to muscle or systemic diseases such as intermittent claudication, to treat shock conditions, to preserve donor tissue and organs used in transplants, in the treatment of cardiovascular diseases including atrial and ventricular arrhythmias, Prinzmetal's (variant) angina, stable angina, and exercise induced angina, congestive heart disease, and myocardial infarction.
A substituted piperazine compound having the following formula:
The compound of claim/wherein m−1 or 2;
A substituted piperazine compound having the following formula:
Dependencies are inferred from the claim text.